{
    "functional_evidence_assessment": [
        {
            "variant_id": {
                "Gene": "PARK2",
                "Protein_Change": {
                    "ref": "C",
                    "alt": "R",
                    "position": "418"
                },
                "variant_string_id": "PARK2 C418R"
            },
            "functional_evidence_aim": "Pathogenic",
            "assessment_steps": [
                {
                    "step_name": "Step 1: Define the disease mechanism",
                    "extracted_paper_info": "Parkinson's disease is a movement disorder characterized by severe loss of dopaminergic neurons, probably through apoptosis. Mutations of the ubiquitin ligase parkin account for most autosomal recessive forms of juvenile Parkinson's disease (AR - JP). Parkin is a p53 transcriptional repressor, and parkin mutations associated with familial AR - JP abolish the parkin - mediated control of p53.",
                    "judgment": "Yes",
                    "reasoning": "The paper clearly states that AR - JP is related to parkin mutations, and parkin's role as a p53 transcriptional repressor and how its mutations affect this function is described, thus defining the disease mechanism related to the functional assay.",
                    "next_step_or_outcome": "Proceed to Step 2"
                },
                {
                    "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
                    "extracted_paper_info": "Assays include caspase - 3 activity measurements, Western blot analyses, p53 activity and promoter transactivation measurements, RT - PCR analysis of p53 mRNAs, Electrophoretic mobility shift assay (EMSA), and Chromatin immunoprecipitation assay (ChIP). These assays are used to study the relationship between parkin, its mutations, and p53 pathway modulation.",
                    "judgment": "Yes",
                    "reasoning": "The assays are relevant to studying the parkin - p53 relationship and how parkin mutations disrupt it, which reflects the disease pathogenesis as defined in Step 1. For example, caspase - 3 activity measurements help understand apoptosis regulation, and ChIP assays show parkin - p53 promoter binding.",
                    "next_step_or_outcome": "Proceed to Step 3"
                },
                {
                    "step_name": "Step 3: Evaluate validity of specific instances of assays",
                    "extracted_paper_info": "Sub - step 3a: Basic Controls and Replicates - Caspase - 3 activity measurements were performed in multiple independent experiments (e.g., n = 10 in some TSM1 neuron experiments for caspase - 3 activation measurements). Western blot analyses, p53 activity and promoter transactivation, and other assays also had multiple independent experiments. Both normal (mock - transfected cells) and abnormal (cells treated with toxins like 6 - OHDA) controls were used in many experiments. Sub - step 3c: Variant Controls - Wild - type parkin was used as a control, and its effect on p53 and caspase - 3 was compared to that of mutants.",
                    "judgment": "Yes",
                    "reasoning": "For Sub - step 3a, both basic controls (normal and abnormal) were used, and multiple replicates were clearly stated in the experiments. For Sub - step 3c, wild - type parkin was used as a control, fulfilling the condition of using a known variant (wild - type as a normal control).",
                    "next_step_or_outcome": "Proceed to Step 4"
                },
                {
                    "step_name": "Step 4: Apply evidence to individual variant interpretation",
                    "extracted_paper_info": "Sub - step 4a: Statistical Analyses - Statistical analysis was performed using PRISM software, with t - test Student or Newmann - Keuls multiple comparison tests for one - way analysis of variance. P - values were reported for various comparisons, such as P < 0.01, P < 0.001, etc. in different experiments related to caspase - 3 activity, p53 expression, and promoter transactivation.",
                    "judgment": "Yes",
                    "reasoning": "The use of statistical tests and reporting of p - values indicates sufficient statistical analyses to estimate the significance of the functional data, thus fulfilling the condition for proceeding to Sub - step 4c.",
                    "next_step_or_outcome": "Proceed to Sub - step 4c"
                },
                {
                    "step_name": "Sub - step 4c: Correlate OddsPath (if statistical analyses were sufficient)",
                    "extracted_paper_info": "Although OddsPath was not directly calculated, the statistical significance (P - values) of differences between wild - type and mutant parkin effects on p53 - related parameters (expression, promoter transactivation, caspase - 3 activity) was reported. For example, wild - type parkin significantly decreased caspase - 3 activity (43% of reduction, n = 6, P < 0.05) in 6 - OHDA - treated SH - SY5Y cells compared to mock - transfected cells, while mutants like C418R did not show this reduction and instead increased p53 - related parameters.",
                    "judgment": "PS3_moderate",
                    "reasoning": "Based on the significant differences in p53 - related functional parameters between wild - type and the C418R mutant, and although OddsPath was not directly given, the consistent and significant disruption of parkin's normal function (p53 repression) by the C418R mutation suggests a moderate level of evidence for pathogenicity. If we were to assume OddsPath interpretation, the significant effects would likely place it in the moderate range for PS3.",
                    "next_step_or_outcome": "Final determination of evidence strength"
                }
            ],
            "final_evidence_strength": {
                "type": "Pathogenic",
                "strength": "PS3_moderate"
            },
            "overall_conclusion": "The C418R variant in PARK2 was assessed. The disease mechanism was clearly defined, and the assays used were applicable to the disease pathogenesis. Basic controls, replicates, and variant controls were used. Statistical analyses were sufficient. Based on the significant disruption of parkin's normal function (p53 repression) by this mutation, a PS3_moderate strength was assigned, indicating moderate evidence for pathogenicity."
        },
        {
            "variant_id": {
                "Gene": "PARK2",
                "Protein_Change": {
                    "ref": "C",
                    "alt": "R",
                    "position": "441"
                },
                "variant_string_id": "PARK2 C441R"
            },
            "functional_evidence_aim": "Pathogenic",
            "assessment_steps": [
                {
                    "step_name": "Step 1: Define the disease mechanism",
                    "extracted_paper_info": "Parkinson's disease is a movement disorder characterized by severe loss of dopaminergic neurons, probably through apoptosis. Mutations of the ubiquitin ligase parkin account for most autosomal recessive forms of juvenile Parkinson's disease (AR - JP). Parkin is a p53 transcriptional repressor, and parkin mutations associated with familial AR - JP abolish the parkin - mediated control of p53.",
                    "judgment": "Yes",
                    "reasoning": "The paper clearly states the disease mechanism related to parkin mutations and its role in relation to p53, which is relevant to the functional assay of this variant.",
                    "next_step_or_outcome": "Proceed to Step 2"
                },
                {
                    "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
                    "extracted_paper_info": "Assays include caspase - 3 activity measurements, Western blot analyses, p53 activity and promoter transactivation measurements, RT - PCR analysis of p53 mRNAs, Electrophoretic mobility shift assay (EMSA), and Chromatin immunoprecipitation assay (ChIP). These assays are used to study the relationship between parkin, its mutations, and p53 pathway modulation.",
                    "judgment": "Yes",
                    "reasoning": "The assays are relevant to understanding how the C441R mutation affects the parkin - p53 relationship and disease - related processes, reflecting the defined disease pathogenesis.",
                    "next_step_or_outcome": "Proceed to Step 3"
                },
                {
                    "step_name": "Step 3: Evaluate validity of specific instances of assays",
                    "extracted_paper_info": "Sub - step 3a: Basic Controls and Replicates - Caspase - 3 activity measurements were performed in multiple independent experiments (e.g., n = 10 in some TSM1 neuron experiments for caspase - 3 activation measurements). Western blot analyses, p53 activity and promoter transactivation, and other assays also had multiple independent experiments. Both normal (mock - transfected cells) and abnormal (cells treated with toxins like 6 - OHDA) controls were used in many experiments. Sub - step 3c: Variant Controls - Wild - type parkin was used as a control, and its effect on p53 and caspase - 3 was compared to that of mutants.",
                    "judgment": "Yes",
                    "reasoning": "For Sub - step 3a, both basic controls (normal and abnormal) were used, and multiple replicates were clearly stated. For Sub - step 3c, wild - type parkin was used as a control, fulfilling the condition of using a known variant (wild - type as a normal control).",
                    "next_step_or_outcome": "Proceed to Step 4"
                },
                {
                    "step_name": "Step 4: Apply evidence to individual variant interpretation",
                    "extracted_paper_info": "Sub - step 4a: Statistical Analyses - Statistical analysis was performed using PRISM software, with t - test Student or Newmann - Keuls multiple comparison tests for one - way analysis of variance. P - values were reported for various comparisons, such as P < 0.01, P < 0.001, etc. in different experiments related to caspase - 3 activity, p53 expression, and promoter transactivation.",
                    "judgment": "Yes",
                    "reasoning": "The use of statistical tests and reporting of p - values indicates sufficient statistical analyses to estimate the significance of the functional data, thus fulfilling the condition for proceeding to Sub - step 4c.",
                    "next_step_or_outcome": "Proceed to Sub - step 4c"
                },
                {
                    "step_name": "Sub - step 4c: Correlate OddsPath (if statistical analyses were sufficient)",
                    "extracted_paper_info": "Although OddsPath was not directly calculated, the statistical significance (P - values) of differences between wild - type and mutant parkin effects on p53 - related parameters (expression, promoter transactivation, caspase - 3 activity) was reported. For example, wild - type parkin significantly decreased caspase - 3 activity (43% of reduction, n = 6, P < 0.05) in 6 - OHDA - treated SH - SY5Y cells compared to mock - transfected cells, while mutants like C441R did not show this reduction and instead increased p53 - related parameters.",
                    "judgment": "PS3_moderate",
                    "reasoning": "Based on the significant differences in p53 - related functional parameters between wild - type and the C441R mutant, and although OddsPath was not directly given, the consistent and significant disruption of parkin's normal function (p53 repression) by the C441R mutation suggests a moderate level of evidence for pathogenicity. If we were to assume OddsPath interpretation, the significant effects would likely place it in the moderate range for PS3.",
                    "next_step_or_outcome": "Final determination of evidence strength"
                }
            ],
            "final_evidence_strength": {
                "type": "Pathogenic",
                "strength": "PS3_moderate"
            },
            "overall_conclusion": "The C441R variant in PARK2 was assessed. The disease mechanism was clearly defined, and the assays used were applicable to the disease pathogenesis. Basic controls, replicates, and variant controls were used. Statistical analyses were sufficient. Based on the significant disruption of parkin's normal function (p53 repression) by this mutation, a PS3_moderate strength was assigned, indicating moderate evidence for pathogenicity."
        },
        {
            "variant_id": {
                "Gene": "PARK2",
                "Protein_Change": {
                    "ref": "K",
                    "alt": "N",
                    "position": "161"
                },
                "variant_string_id": "PARK2 K161N"
            },
            "functional_evidence_aim": "Pathogenic",
            "assessment_steps": [
                {
                    "step_name": "Step 1: Define the disease mechanism",
                    "extracted_paper_info": "Parkinson's disease is a movement disorder characterized by severe loss of dopaminergic neurons, probably through apoptosis. Mutations of the ubiquitin ligase parkin account for most autosomal recessive forms of juvenile Parkinson's disease (AR - JP). Parkin is a p53 transcriptional repressor, and parkin mutations associated with familial AR - JP abolish the parkin - mediated control of p53.",
                    "judgment": "Yes",
                    "reasoning": "The paper clearly defines the disease mechanism in relation to parkin mutations and its role in p53 regulation, which is relevant to the functional assay of this variant.",
                    "next_step_or_outcome": "Proceed to Step 2"
                },
                {
                    "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
                    "extracted_paper_info": "Assays include caspase - 3 activity measurements, Western blot analyses, p53 activity and promoter transactivation measurements, RT - PCR analysis of p53 mRNAs, Electrophoretic mobility shift assay (EMSA), and Chromatin immunoprecipitation assay (ChIP). These assays are used to study the relationship between parkin, its mutations, and p53 pathway modulation.",
                    "judgment": "Yes",
                    "reasoning": "The assays are relevant to understanding how the K161N mutation impacts the parkin - p53 relationship and disease - related processes, reflecting the defined disease pathogenesis.",
                    "next_step_or_outcome": "Proceed to Step 3"
                },
                {
                    "step_name": "Step 3: Evaluate validity of specific instances of assays",
                    "extracted_paper_info": "Sub - step 3a: Basic Controls and Replicates - Caspase - 3 activity measurements were performed in multiple independent experiments (e.g., n = 10 in some TSM1 neuron experiments for caspase - 3 activation measurements). Western blot analyses, p53 activity and promoter transactivation, and other assays also had multiple independent experiments. Both normal (mock - transfected cells) and abnormal (cells treated with toxins like 6 - OHDA) controls were used in many experiments. Sub - step 3c: Variant Controls - Wild - type parkin was used as a control, and its effect on p53 and caspase - 3 was compared to that of mutants.",
                    "judgment": "Yes",
                    "reasoning": "For Sub - step 3a, both basic controls (normal and abnormal) were used, and multiple replicates were clearly stated. For Sub - step 3c, wild - type parkin was used as a control, fulfilling the condition of using a known variant (wild - type as a normal control).",
                    "next_step_or_outcome": "Proceed to Step 4"
                },
                {
                    "step_name": "Step 4: Apply evidence to individual variant interpretation",
                    "extracted_paper_info": "Sub - step 4a: Statistical Analyses - Statistical analysis was performed using PRISM software, with t - test Student or Newmann - Keuls multiple comparison tests for one - way analysis of variance. P - values were reported for various comparisons, such as P < 0.01, P < 0.001, etc. in different experiments related to caspase - 3 activity, p53 expression, and promoter transactivation.",
                    "judgment": "Yes",
                    "reasoning": "The use of statistical tests and reporting of p - values indicates sufficient statistical analyses to estimate the significance of the functional data, thus fulfilling the condition for proceeding to Sub - step 4c.",
                    "next_step_or_outcome": "Proceed to Sub - step 4c"
                },
                {
                    "step_name": "Sub - step 4c: Correlate OddsPath (if statistical analyses were sufficient)",
                    "extracted_paper_info": "Although OddsPath was not directly calculated, the statistical significance (P - values) of differences between wild - type and mutant parkin effects on p53 - related parameters (expression, promoter transactivation, caspase - 3 activity) was reported. For example, wild - type parkin significantly decreased caspase - 3 activity (43% of reduction, n = 6, P < 0.05) in 6 - OHDA - treated SH - SY5Y cells compared to mock - transfected cells, while mutants like K161N did not show this reduction and instead increased p53 - related parameters.",
                    "judgment": "PS3_moderate",
                    "reasoning": "Based on the significant differences in p53 - related functional parameters between wild - type and the K161N mutant, and although OddsPath was not directly given, the consistent and significant disruption of parkin's normal function (p53 repression) by the K161N mutation suggests a moderate level of evidence for pathogenicity. If we were to assume OddsPath interpretation, the significant effects would likely place it in the moderate range for PS3.",
                    "next_step_or_outcome": "Final determination of evidence strength"
                }
            ],
            "final_evidence_strength": {
                "type": "Pathogenic",
                "strength": "PS3_moderate"
            },
            "overall_conclusion": "The K161